Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Pharmaceutical Executive: March 2025 Interactive Digital Edition

Articles in this issue

Trending on PharmExec

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

The Industry’s Communication and Engagement with FDA

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing